F16.24

Hallucinogen dependence with hallucinogen-induced mood disorder

Risk-adjusting (HCC)Billable code

HCC risk adjustment mapping

CMS-HCC V28

HCC137

Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications

CMS-HCC ESRD V24

HCC55

Substance Use Disorder, Moderate/Severe, or Substance Use with Complications

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

This code · F16.24
Synonyms

Other hallucinogen use disorder, moderate, with other hallucinogen induced bipolar or related disorder Other hallucinogen use disorder, moderate, with other hallucinogen induced depressive disorder Other hallucinogen use disorder, severe, with other hallucinogen-induced bipolar or related disorder Other hallucinogen use disorder, severe, with other hallucinogen-induced depressive disorder Phencyclidine use disorder, moderate, with phencyclidine induced bipolar or related disorder Phencyclidine use disorder, moderate, with phencyclidine induced depressive disorder Phencyclidine use disorder, severe, with phencyclidine induced bipolar or related disorder Phencyclidine use disorder, severe, with phencyclidine-induced depressive disorder

Inherited from F16.2Hallucinogen dependence
Excludes 1

hallucinogen abuse (F16.1-) hallucinogen use, unspecified (F16.9-)

Inherited from F16Hallucinogen related disorders
Includes

ecstasy PCP phencyclidine

Inherited from chapter 5Mental, Behavioral and Neurodevelopmental disorders
Includes

disorders of psychological development

Excludes 2

symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)

Official Guidelines for F16.24

FY 2026 ›